98%
921
2 minutes
20
Background: Long-acting reversible contraceptives such as intrauterine devices (IUDs) are highly effective in preventing pregnancy, cost effective, and increasing in popularity. It is unclear whether changes in IUD use are associated with changes in rates of irreversible tubal sterilization. In this analysis, we evaluate changes in rates of tubal sterilization, insertion of copper or levonorgestrel (LNG) IUDs, and related complications over time.
Methods: Data were obtained from a retrospective claims database (Optum Clinformatics Data Mart) of women aged 15 to 45 years who underwent insertion of copper or LNG IUD or tubal sterilization between 1/1/2006 and 12/31/2011. Outcomes of interest included annual rates of insertion or sterilization and annual rates of potential complications and side effects.
Results: The number of women included in the analysis each year ranged from 1,870,675 to 2,016,916. Between 2006 and 2011, copper IUD insertion claim rates increased from 0.18 to 0.25% and LNG IUD insertion claim rates increased from 0.63 to 1.15%, while sterilization claims decreased from 0.78 to 0.66% (P < 0.0001 for all comparisons). Increases in IUD insertion were apparent in all age groups; decreases in tubal sterilization occurred in women aged 20 to 34 years. The most common side effects and complications were amenorrhea (7.36-11.59%), heavy menstrual bleeding (4.85-15.69%), and pelvic pain (11.12-14.27%). Significant increases in claims of certain complications associated with IUD insertion or sterilization were also observed.
Conclusion: Between 2006 and 2011, a decrease in sterilization rates accompanied an increase in IUD insertion rates, suggesting that increasing numbers of women opted for reversible methods of long-term contraception over permanent sterilization.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465441 | PMC |
http://dx.doi.org/10.1186/s12978-017-0334-1 | DOI Listing |
Contraception
August 2025
Department of Medicine, University of California San Francisco, 1001 Potrero Ave, San Francisco, CA, USA 94114. Electronic address:
Objective: Barriers to contraceptive access in the United States have intensified following the 2022 Dobbs decision, disproportionately affecting marginalized populations. This study aimed to develop and validate the Access to Contraceptive Care and Early Abortion Support Services (ACCESS) measure to assess key dimensions of contraceptive access.
Study Design: We followed a sequential approach to measure development, including: (1) defining constructs and generating items based on existing access frameworks; (2) expert review (n=30); (3) cognitive interviews with patients (n=14); (4) survey administration as part of a randomized trial of individuals considering tubal sterilization (N=440); and (5) psychometric analyses, including exploratory factor analysis and reliability testing.
Salud Colect
July 2025
Physician, specialist in General Medicine. Master's degree in Gender, Society, and Politics. President, Federación Argentina de Medicina General. Member, Policies and Collective Actions project, Facultad de Ciencias Humanas, Universidad Nacional de La Pampa, Santa Rosa, Argentina. pilargalende@gmai
Tubal ligation access in the province of La Pampa is regulated by Provincial Law 2079 and National Law 26130. Although the only legal requirements are to be over 16 years of age and to sign an informed consent form, in practice there are barriers stemming from institutionalized heteronormativity. This normative framework privileges certain profiles of women while resisting the procedure for others, despite their status as rights-holders.
View Article and Find Full Text PDFMed Hist
July 2025
https://ror.org/03r8z3t63University of New South Wales, Sydney, New South Wales, Australia.
Surgical sterilisation practices significantly increased in contraceptive capacity as the twentieth century unfolded. Despite this prolific uptake, sterilisation is markedly absent from histories of birth control and family planning and instead has remained addressed within histories of eugenics and coercion. The purpose of this article is twofold: firstly, to demonstrate a voluntary, contraceptive history of sterilisation that is distinct from, though connected to, involuntary and eugenic sterilisation; and secondly, to explain the integral role that individual doctors and their private practice played in the rise of contraceptive sterilisation in twentieth-century Australia.
View Article and Find Full Text PDFJ Womens Health (Larchmt)
July 2025
Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Sickle cell disease (SCD) is associated with high-risk pregnancy and low rates of hormonal contraception use. Intersectional vulnerabilities among individuals with SCD in the United States raise historically and socially contingent questions about tubal sterilization (TS), yet immediate postpartum TS rates among individuals with SCD remain unknown. Using the 2012-2019 National Inpatient Sample, we conducted a repeated cross-sectional study to estimate the rate of TS among delivery hospitalizations for people with SCD, without SCD (non-SCD), Black people with and without SCD, and people with cystic fibrosis (CF).
View Article and Find Full Text PDFContraception
October 2025
University of California, San Diego, Division of Complex Family Planning, Department of Obstetrics, Gynecology, and Reproductive Sciences, La Jolla, CA, United States.
Objective: This study aimed to describe the experience of nulliparous individuals aged <30 years when seeking permanent female contraception.
Study Design: We recruited nulliparous individuals aged <30 years who underwent permanent female contraception in the United States in the last 2 years through a clinical Listserv, Facebook, and Reddit to participate in semistructured in-depth interviews. We summarized themes using the socioecological model.